Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 152 (2), 298-9

Origin of Stimulant Use for Treatment of Attention Deficit Disorder

Origin of Stimulant Use for Treatment of Attention Deficit Disorder

M D Gross. Am J Psychiatry.

Similar articles

See all similar articles

Cited by 6 PubMed Central articles

  • From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate
    FP Busardò et al. Curr Neuropharmacol 14 (1), 17-27. PMID 26813119. - Review
    Methylphenidate (MPD) is a central nervous system (CNS) stimulant, which belongs to the phenethylamine group and is mainly used in the treatment of attention deficit hype …
  • Attention Deficit Hyperactivity Disorder
    M Kulkarni. Indian J Pediatr 82 (3), 267-71. PMID 25186567. - Review
    Attention Deficit Hyperactivity Disorder (ADHD) is a common behavioral disorder in children. It is characterized by motor hyperactivity, impulsivity and inattention inapp …
  • Psychostimulant Addiction Treatment
    KA Phillips et al. Neuropharmacology 87, 150-60. PMID 24727297. - Review
    Treatment of psychostimulant addiction has been a major, and not fully met, challenge. For opioid addiction, there is strong evidence for the effectiveness of several med …
  • The History of Attention Deficit Hyperactivity Disorder
    KW Lange et al. Atten Defic Hyperact Disord 2 (4), 241-55. PMID 21258430.
    The contemporary concept of attention deficit hyperactivity disorder (ADHD) as defined in the DSM-IV-TR (American Psychiatric Association 2000) is relatively new. Excessi …
  • Attention Deficit/Hyperactivity Disorder: Pharmacotherapy
    J Elia. Psychiatry (Edgmont) 2 (1), 27-35. PMID 21179640.
    Pharmacotherapy, one of the effective modalities of treatment for attention deficit/hyperactivity disorder (ADHD), was discovered serendipitously and, until recently, con …
See all "Cited by" articles

MeSH terms

Feedback